BIOSAVITA
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, single domain antibodies, antibody-drug conjugates and fusion proteins. They are focused on developing novel biological drugs and vaccines in partnership with biopharmaceutical companies and government agencies.
BIOSAVITA
Industry:
Biotechnology Health Care Manufacturing
Founded:
1994-06-01
Address:
Plymouth, Michigan, United States
Country:
United States
Website Url:
http://www.biosavita.com
Total Employee:
1+
Status:
Active
Contact:
(205) 447-1180
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS COVID-19
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.biosavita.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BioSavita"
Accelerated Biologics Development | BioSavita, Inc
BioSavita, Inc. Nalini Motwani, Ph.D., President . [email protected] . Phone: 734-233-3146 Mobile: 248-320-5562. Life Science & Innovation Corridor 46701 Commerce Center Drive Plymouth, MI 48170. Send us a message! …See details»
BioSavita - Crunchbase Company Profile & Funding
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, single domain antibodies, antibody-drug conjugates …See details»
Contact - BioSavita, Inc
BioSavita, Inc. Nalini Motwani, Ph.D., President . [email protected]. Phone: 734-233-3146 Mobile: 248-320-5562. Life Science & Innovation CorridorSee details»
Management Team - BioSavita, Inc
Mr. Joseph DeAngelo is a founding Scientist of BioSavita. Mr. DeAngelo is also the founder and CEO of Cereva Biotechnology Corp whose mission is to engineer yeast for the production …See details»
BioSavita - Contacts, Employees, Board Members, Advisors & Alumni
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, ... Experience the new Crunchbase, powered by AI . …See details»
BioSavita Company Profile - Office Locations, Competitors ... - Craft
BioSavita (formerly ApoLife) is a company that is focused on developing biological drugs and vaccines. It leverages synthetic DNA technologies to manufacture functional antibodies, …See details»
BioSavita, Inc. Company Profile | Plymouth, MI | Competitors ...
Find company research, competitor information, contact details & financial data for BioSavita, Inc. of Plymouth, MI. Get the latest business insights from Dun & Bradstreet.See details»
BioSavita - Funding, Financials, Valuation & Investors - Crunchbase
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, ... Experience the new Crunchbase, powered by AI . …See details»
BioSavita, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore BioSavita, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
BioSavita - Michigan Life Sciences & Innovation Center
BioSavita is focused on rapidly bringing new biosimilar medicines to patients in partnership with biopharmaceutical companies. We have developed proprietary genetically engineered strains …See details»
BioSavita - Products, Competitors, Financials, Employees, …
BioSavita is a biotechnology company focused on accelerated biologics development. Use the CB Insights Platform to explore BioSavita's full profile. BioSavita - Products, Competitors, …See details»
BioSavita - VentureRadar
Curia Unknown n/a Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum …See details»
BioSavita - Crunchbase
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, Search Crunchbase. Start Free Trial . Chrome …See details»
BioSavita | Plymouth, MI, USA Startup - gust.com
BioSavita licenses a yeast based antibody expression platform to biopharma for development and production of biosimilar cancer antibodies. Large pharma uses the platform as well as the …See details»
BioSavita, Inc. - CMOCRO
BioSavita\\'s high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, single domain antibodies, antibody-drug conjugates …See details»
Nalini Motwani, Ph.D. - biosavita.com
As a founder of BioSavita, she has been successful in receiving NIH grant funding and has invented patented novel yeast platform technologies that describe the rapid and cost-effective …See details»
BioSavita - Overview, News & Similar companies | ZoomInfo.com
Who is BioSavita. September 2012 BioSavita is a biotechnology company focused on accelerating therapeutic antibody development for our Antibodies are the newest phar …See details»
OUR TECHNOLOGY - BioSavita, Inc
BioSavita uses synthetic biological approaches and provides a platform for construction of “yeast factories” for the accelerated and cost-effective production of recombinant antibodies, proteins …See details»
BioSavita - EquityNet
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, single domain antibodies, antibody-drug conjugates …See details»
BioSavita - Tech Stack, Apps, Patents & Trademarks - Crunchbase
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, New. Resources. ... Log In. Experience the new …See details»